Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence

This study has been completed.
Sponsor:
Collaborator:
Catalyst Pharmaceuticals, Inc.
Information provided by:
New York University School of Medicine
ClinicalTrials.gov Identifier:
NCT00527683
First received: September 10, 2007
Last updated: April 7, 2008
Last verified: April 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2007
  Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):